Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency Through the Eyes of Patients and Parents; Burden of Illness Perspectives From Patients and Parents Who Speak English, French or German

NCT04372446 is registered in ClinicalTrials.gov with Inozyme Pharma as lead sponsor.

NCT NCT04372446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04372446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency Through the Eyes of Patients and Parents; Burden of Illness Perspectives From Patients and Parents Who Speak English, French or German
Lead sponsor
Inozyme Pharma
Phase
Observational
Overall status
Completed
Start date
May 6, 2020
Completion date
September 30, 2020
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal recessive hypophosphatemic rickets type 2, generalized arterial calcification in infancy